Globe Pulsed Field System
Kardium, Inc. · Decision date Jan 6, 2026
What did the FDA decide?
FDA records P240044/S003 as a supplement to PMA P240044, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jan 6, 2026.
FDA approval order statement
a manufacturing change to replace a Nd:YAG (Neodymium-doped Yttrium Aluminum Garnet) laser welder with a fiber laser welder for producing the coupling subassembly at the distal end of the catheter shaft
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Jan 6, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P240044/S003
- Regulatory pathway
- PMA supplement
- Applicant
- Kardium, Inc.
- Product code
- QZI
- Decision code
- OK30
- Decision date
- Jan 6, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation.
- Applicant
- Kardium, Inc.
- Product code
- QZI
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P240044. Subsequent supplements may change the device or its indications.
FDA decision timeline
P240044 · Original PMA
Globe Pulsed Field System
P240044/S003 received
Application receipt date recorded by FDA.
P240044/S003 · FDA decision
30-Day Notice
P240044/S004 · Related supplement
Globe Catheter; Globe Pulsed Field System
P240044/S002 · Related supplement
Globe Catheter (601-01000)
P240044/S005 · Related supplement
Globe Catheter; Globe Pulsed Field System
P240044/S001 · Related supplement
Globe Catheter and Globe Pulsed Field System
P240044/S006 · Related supplement
Globe Catheter Laminated Ribs
P240044/S008 · Related supplement
Globe Pulsed Field System; Globe Catheter
P240044/S007 · Related supplement
Globe Catheter and Globe Pulsed Field System
Timeline entries are records held by MedtechLedger for P240044. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P240044
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Globe Pulsed Field SystemP240044 | Kardium, Inc. | PMA approval | Aug 27, 2025 | FDA |
Globe Catheter; Globe Pulsed Field SystemP240044/S004 | Kardium, Inc. | PMA supplement | Jan 9, 2026 | FDA |
Globe Catheter (601-01000)P240044/S002 | Kardium, Inc. | PMA supplement | Feb 18, 2026 | FDA |
Globe Catheter; Globe Pulsed Field SystemP240044/S005 | Kardium, Inc. | PMA supplement | Jun 12, 2026 | FDA |
Globe Catheter and Globe Pulsed Field SystemP240044/S001 | Kardium, Inc. | PMA supplement | Jun 23, 2026 | FDA |
Globe Catheter Laminated RibsP240044/S006 | Kardium, Inc. | PMA supplement | Aug 20, 2026 | FDA |
Globe Pulsed Field System; Globe CatheterP240044/S008 | Kardium, Inc. | PMA supplement | Oct 23, 2026 | FDA |
Globe Catheter and Globe Pulsed Field SystemP240044/S007 | Kardium, Inc. | PMA supplement | Oct 27, 2026 | FDA |
Explore the linked device profile
Other records with product code QZI
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Varipulse Bi-Directional CatheterP240006/S018 | Biosense Webster, Inc. | PMA supplement | Nov 3, 2026 | FDA |
Volt PFA SystemP250022/S002 | ABBOTT MEDICAL | PMA supplement | Oct 15, 2026 | FDA |
Affera Sphere-9 Mapping and Ablation CatheterP240013/S032 | Medtronic, Inc. | PMA supplement | Oct 9, 2026 | FDA |
Volt PFA Catheter, Sensor EnabledP250022/S009 | ABBOTT MEDICAL | PMA supplement | Oct 8, 2026 | FDA |
VOLT PFA CATHETER, SENSOR ENABLEDP250022/S012 | ABBOTT MEDICAL | PMA supplement | Oct 8, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Kardium, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 8518 Glenlyon Pkwy., Unit 155, Burnaby, V5J OB6
Sources and methodology
- Original FDA record: P240044/S003
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

